Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 38 studies with search of: | "Exelixis" [Exact] |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Study of XL999 in Patients With Metastatic Colorectal Cancer
|
||||
2 | Active, not recruiting |
Study of XL184 in Adults With Advanced Malignancies
|
||||
3 | Recruiting |
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
|
||||
4 | Terminated |
Study of XL999 in Patients With Metastatic Renal Cell Carcinoma
|
||||
5 | Completed |
Study of XL999 in Adults With Solid Tumors
|
||||
6 | Recruiting |
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
|
||||
7 | Recruiting |
Study of the Safety and Pharmacokinetics of XL765 in Adults With Solid Tumors
|
||||
8 | Completed |
Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors
|
||||
9 | Completed |
Study of XL999 in Patients With Non-Small Cell Lung Cancer
|
||||
10 | Recruiting |
A Phase 1 Study of XL019 in Adults With Polycythemia Vera
|
||||
11 | Recruiting |
Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer
|
||||
12 | Completed |
Study of XL820 Given Orally Daily to Subjects With Solid Tumors
|
||||
13 | Recruiting |
Study of the Safety and Pharmacokinetics of XL147 in Adults With Solid Tumors
|
||||
14 | Active, not recruiting |
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
|
||||
15 | Recruiting |
Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies
|
||||
16 | Recruiting |
Safety Study of XL147 in Combination With Erlotinib in Adults With Solid Tumors
|
||||
17 | Active, not recruiting |
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
|
||||
18 | Recruiting |
Safety Study of XL147 in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
|
||||
19 | Recruiting |
A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
|
||||
20 | Active, not recruiting |
Study of XL647 Administered Orally Daily to Patients With Solid Tumors
|
Previous Page | Studies Shown (1-20) | Next (21-38) |